27 Jun RxAdvocate June, 2023 — Newsletter
FDA approves Rinvoq for Crohn's Disease Humira Biosimilars Congenital Heart Disease Community Involvement ...
Newsletter
17 May RxAdvocate May, 2023 — Newsletter
FDA Update: Opioids Advertising on Weight Loss Medication OTC Hearing Aids ...
13 Apr RxAdvocate April, 2023 — Newsletter
COVID Update Drug Shortages OTC Narcan Announcements...
10 Mar RxAdvocate March, 2023 — Newsletter
New Hemophilia A Drug RSV Vaccine Wegovy and Ozempic Insulin Prices...
23 Feb RxAdvocate February, 2023 — Newsletter
Humira Biosimilar Mounjaro Marketing New Cancer Drugs Approval...
23 Feb RxAdvocate January, 2023 — Newsletter
Cervical Cancer Awareness Alzheimer's Treatment 5 Questions Facing the Pharmaceutical Industry...
23 Feb RxAdvocate December, 2022 — Newsletter
FDA Approves new Hemophilia B Drug US Drug Supplies Tripledemic Annual Leadership Onsite...
22 Feb RxAdvocate November, 2022 — Newsletter
Opiod Epidemic Lawsuits Overdose Reversal OTC New Discount Card Partnership...
22 Feb RxAdvocate October, 2022 — Newsletter
Malaria Vaccine Botox Rival Revance Gets U.S. Approval COVID-19 Vaccine Boosters Organizational Announcement Team Community Involvement ...
22 Feb RxAdvocate September, 2022 — Newsletter
Malaria Vaccine Botox Rival Revance Gets U.S. Approval COVID-19 Vaccine Boosters Organizational Announcement Team Community Involvement ...